
CRISPRed Pigs, Exscientia Fires CEO, & AGBT Roundup; Christian Henry
About this episode
Episode 9 (February 16, 2024): Using CRISPR-Cas9 technology, British animal genetics firm Genus has generated a population of pigs that are resistant to the deadly porcine reproductive and respiratory syndrome (PRRS) virus. Exscientia has fired its founder, CEO, and principal executive officer Andrew Hopkins, PhD, and removed him from the company’s board, after it concluded that he engaged in “inappropriate” relationships with two employees. Julianna LeMieux, PhD, Deputy Editor in Chief at GEN, provides a recap of her time at AGBT 2024.
Plus, an interview with Christian Henry, president and chief executive officer at PacBio.
Listed below are key references to the GEN stories, media, and other items discussed in this episode of Touching Base:
CRISPRed Pigs: Precision Porcine Gene Editing Combats PPRS Virus Threat
By Uduak Thomas, GEN, February 14, 2024
Exscientia Fires CEO for “Inappropriate” Relationships with Two Employees
GEN, February 13, 2024
Sun, Spatial, and Sequencing: A Report from the First Day of AGBT
By Julianna LeMieux, PhD, and Jonathan D. Grinstein, PhD, GEN, February 7, 2024
NanoString CSO Joe Beechem Insists the Company “Not Going Anywhere”
By Julianna LeMieux, PhD, GEN, February 8, 2024
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time Touching Base publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Touching Base

BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C...
Touching Base

Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors for Huntingt...
Touching Base

Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics
Touching Base

Merck and Insilico Make Deals, Claude Science’s Debut, Vaccines for Neglected Di...
Touching Base